CONTACT LENSES TODAY
October 14, 2007
Contact Lenses Today® is edited by Dr. Carla Mack and the staff of Contact Lens Spectrum. This week CLToday®
reaches more than 12,000 readers in 74 countries.
NAD Recommends Bausch & Lomb Discontinue Claims for ReNu MultiPlus Regarding Sales and 'Trust'
The National Advertising Division (NAD) of the Council of Better Business Bureaus, one of the investigative arms of the
advertising industry’s voluntary self-regulation program, has recommended that Bausch & Lomb, Inc. discontinue claims that suggest that ReNu MultiPlus
Solution is the top-selling or most "trusted" among contact lens wearers. The advertising claims made by B&L were challenged by Alcon Laboratories, Inc.,
maker of Opti-Free Express.
Specifically, the following claims were challenged: "ReNu MultiPlus Solution is a solution for soft
contact lenses. It is the #1 selling Multi-purpose formula in the U.S." and ReNu MultiPlus "has been trusted by over 20 million contact lens wearers and
their eye care professionals."
In its decision, NAD noted that it is undisputed that Alcon’s Opti-Free Express is currently the
leading selling manufacturer brand of multi-purpose solution in the U.S. market, however, nothing in its decision precludes B&L from making an expressly
qualified claim that the formula sold under the brand name ReNu MultiPlus together with the same formula as private label store brands is the #1 selling
contact lens formula in the United States.
NAD also concluded that the evidence was not sufficient to support the advertiser’s
claim that ReNu MultiPlus "has been trusted by over 20 million contact lens wearers and their eye care professionals."
Lomb in its advertiser’s statement said that while it is "disappointed by NAD’s finding that the selection and use by consumers of a medical device does not
equate with consumer trust of the product, Bausch & Lomb will be guided by NAD’s recommendations in its future advertising."
AMO Partners with Eye Care Professionals and Launches Educational Campaign
Advanced Medical Optics, Inc. announced the launch of Elevate Your Eye (EYE) Care, a global education campaign designed to educate
contact lens wearers about proper lens cleaning techniques. The goal of the campaign is to help patients maximize the benefits of contact lens wear while
minimizing the likelihood of infection. EYE Care, which features MTV reality show star Lauren Conrad as a spokesperson, was launched in response to concerns
that contact lens wearers may not be practicing healthy lens care habits.
A recent national survey, part of a new study conducted by
the Contact Lens Council (CLC), found more than 11 million of the 35 million contact lens wearers in the U.S. are not practicing proper contact lens care
techniques and are putting themselves at daily risk for eye infections. (See
Contact Lenses Today August 19, 2007 for more information on the study.) "This survey underscores
the significant disconnect between eye care professionals and their patients when it comes to contact lens care," said David W. Hansen, O.D., F.A.A.O., director,
professional services at AMO. "Eleven million non-compliant contact lens wearers is too high of a number to ignore. Through the EYE Care campaign, we are partnering
with eye care professionals to help patients understand the simple steps to keep their eyes healthy and free from infection, including the importance of using a
solution with a rub and rinse regimen."
American Academy of Ophthalmology Warns Consumers about Decorative Contacts
The American Academy of Ophthalmology issued a reminder to consumers that serious eye disorders can be caused by over-the-counter
lenses. In the statement the Academy noted that those most likely to buy decorative contacts—teens and young adults—are also most likely to be unaware of the
risks these devices can pose to their eyes and life-long visual health.
Although over-the-counter sales of nonprescription "plano"
cosmetic lenses have been illegal in the United States since 2005, decorative contacts are still widely available in retail stores and on the Internet. They are
especially popular at Halloween as accessories to costumes. Because consumers buying over-the-counter are not educated on proper use and care of decorative
contacts, they do not realize the harm that can result from improper use.
The Academy suggested that consumers go to
www.geteyesmart.org, the Academy's public website for more information about cosmetic lenses.
Comfort Delivers Lasting Patient Satisfaction
Nothing drives referrals like satisfied patients. And nothing satisfies patients like the comfort and minimal
corneal staining that can be provided by ACUVUE® OASYS™ Brand Contact Lenses with HYDRACLEAR™ Plus. In a recent clinical
study, new wearers exhibited no significant difference in corneal staining and reported no significant difference in overall comfort
between ACUVUE® OASYS™ and no lens. And in an in-market trial, 89% of patients fit with ACUVUE® OASYS™ would recommend
their doctors based on their experience. How will you satisfy your patients and build your practice with ACUVUE® OASYS™?
More About ACUVUE® OASYS®
Important Safety Information
Alcon and Prevent Blindness America Partner at AARP Annual Meeting to Help Baby Boomers Better Manage Eye Health
At the 2007 American Association of Retired Persons (AARP) Annual Meeting in Boston last month, Alcon, Inc. joined with Prevent
Blindness America to educate Baby Boomers about practical approaches to maintaining healthy eyes and good vision. Together they facilitated more than 400
complimentary eye screenings testing visual acuity and visual field. Alcon also sponsored several informational presentations about glaucoma, cataracts and
dry eye featuring leading ophthalmologists.
According to a 2002 study conducted by Prevent Blindness America, it is estimated that
more than 3.4 million older Americans are legally blind, with the prevalence of blindness or visual impairment increasing rapidly after the age of 75. Many of
these cases could have been prevented if aging Americans took a more proactive approach to their overall eye health.
During the course
of the meeting, Alcon surveyed people being screened and other visitors to its booth to find out what their greatest concerns were with respect to their eyes and
vision. Among the most frequently noted concerns were:
- Contact lens solutions and dryness.
- Dry eyes and therapies to soothe or cure ocular dryness.
- Latest technologies in intraocular lenses, specifically for presbyopia and astigmatism.
- New treatments for macular degeneration.
- Ocular vitamins and
- Therapies for common eye diseases such as glaucoma, cataracts and dry eye.
- Vision loss from glaucoma and the latest surgical techniques.
AMO Announces Management Changes
Advanced Medical Optics, Inc. announced that Michael J. Lambert will join the company on October 15 as chief financial officer. Mr.
Lambert, who has approximately 20 years of experience and a diverse financial background, will oversee the company's finance, accounting, tax, treasury and information
Richard (Randy) A. Meier, who held positions of chief financial officer and chief operating officer at AMO, will
continue as AMO's chief operating officer and assume additional responsibility for management of the company's cataract/implant business and global customer services
function, while maintaining his existing management responsibilities for AMO's eye care business and the company's global manufacturing and supply chain operations. C.
Russell Trenary, III, who was previously president of the company's cataract/implant business, has been named executive vice president of global public policy and medical
education encompassing all of AMO's businesses and product lines.
Keratoconus Congress 2007 – Agenda Available
The agenda for the second Global Keratoconus Congress is now available online. The event will be hosted at
Bally’s in Las Vegas, January 25-27, 2008. Please visit http://www.GKCongress.com. There you will
find the educational program agenda and information on hotel accommodations, as well as the ability to register for the event. The program
will be accredited for continuing education under COPE, NCLE and JCAHPO.
Companies interested in exhibiting should contact Heather
Seasholtz at 215-643-8073.
Scleral Contact Lenses in the Management of AKC
This study from the Cornea Service, Cole Eye Institute at Cleveland Clinic, described the use of rigid gas-permeable scleral contact
lenses (ScCL) in the treatment and visual rehabilitation of patients with medically controlled advanced atopic keratoconjunctivitis (AKC). The authors conducted a
retrospective chart review of 10 eyes with medically controlled advanced AKC whose treatment included the use of ScCL for protection of the cornea from the ocular
surface environment and visual rehabilitation. Outcomes measured were changes in biomicroscopic findings and visual acuity.
post-fitting median follow-up period was 20.5 months (range, 14-32 months). An improvement in conjunctival hyperemia and corneal epithelial defects was observed in
all eyes. Median best-corrected visual acuity before ScCL was logMAR 0.651 (Snellen 20/90; range, 20/45-20/400). After proper ScCL fitting, median logMAR visual
acuity was 0.239 (Snellen 20/35; range, 20/20-20/50; P = 0.001). All patients gained at least 1 line of vision after initiation of ScCL, and 9 of 10 eyes experienced
an improvement of at least 2 lines of vision. ScCL use was well tolerated by all patients, and no complications or infections occurred as a result of ScCL wear.
The authors concluded that rigid gas-permeable ScCL are useful and safe to use in the management of the ocular surface and in the visual rehabilitation of eyes with
medically controlled advanced AKC.
Margolis R, Thakrar V, Perez VL. Role of rigid gas-permeable scleral contact lenses in the management of advanced atopic
keratoconjunctivitis. Cornea. 2007 Oct;26(9):1032-4.
Let Your Patients Decide
In the few months that I've been the editor for Contact Lenses Today, you have probably noticed that I write often about providing the
best for your patients. I spoke with many eye care practitioners last weekend at the EastWest Eye Conference in Cleveland, Ohio. As I talked about contact lens
innovation, there was a subset of practitioners who repeatedly stated, "My patients can't afford it." Do you want to be known as the practice that gives your services
and products away and has the lowest fees? Or, do you want to be known as the practice that offers value to your patients? Patients will pay for expertise. Patients
will pay for convenience. Patients will be pay for health. Patients will pay for value. Offer your patients the best and then let them make the decision. Don't make
the decision for them.
Carla Mack, O.D., F.A.A.O.
This month at http://www.siliconehydrogels.org explore the significance of the recent "no-rub" solution recalls, learn
about atypical upper lid margin staining in dry-eyed silicone hydrogel wearers and review the latest in silicone hydrogel research present at ARVO 2007.
Report adverse contact lens reactions here: http://www.accessdata.fda.gov/scripts/medwatch/ or
call (800) FDA-1088.
Send your favorite tips to firstname.lastname@example.org -- if your tip is selected as 'Best
of the Month,' you'll receive a free T-shirt (see http://www.CLToday.com for details). Please include your full name, degree or
title and city/state/country.
For more information on Contact Lenses Today including archives of previous issues or to subscribe to this newsletter, please visit our website at
For the latest articles on contact lenses, important clinical information and helpful tools related to the
contact lens practice go to www.clspectrum.com.
CLToday Services: Subscribe; Unsubscribe; submit
news to email@example.com; or, fax 1-215-643-3902.
Contact Lenses Today and CLToday are registered trademarks of Lippincott, Williams and Wilkins, Inc.
©2007 Lippincott, Williams and Wilkins, Inc.
This has been a BCI e-mail communication. If you prefer not to receive e-mail from us, please use the following
to remove your e-mail address from our list:
You are receiving this e-mail because you have agreed to receive e-mail communications from Lippincott, Williams and Wilkins, Inc.
Lippincott, Williams and Wilkins, Inc. - 1300 Virginia Drive Suite 400 Fort Washington PA 19034 | 215-643-8000
Lippincott, Williams and Wilkins, Inc. e-mail program complies with the Federal Can-Spam Act of 2003
Please take a moment to make sure your newsletters don't get marked as spam.
Add firstname.lastname@example.org to your 'approved senders' list or address book.